Gamida, college unveil study of gene therapy for blood diseases

12/3/2009 | Globes (Israel)

Israel-based Gamida Cell and the Weill Cornell Medical College have unveiled a feasibility study to test the safety and effectiveness of a gene treatment that could be used to treat beta thalassemia and other forms of congenital anemia. The gene therapy uses technologies developed by Gamida and Weill Cornell.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD